The 2019 Liberate Life Bike Ride is the fourth Sobi
charity ride to raise funds for the European Haemophilia Consortium (EHC).
Science-led biopharmaceutical company AstraZeneca Plc (LON:AZN) announced on Thursday that it has agreed to buy a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) for a total cash consideration of USD95m from a subsidiary of Swedish Orphan Biovitrum AB (Sobi
The total upfront consideration corresponds to SEK 13.6bn (USD 1,500m) consisting of SEK 9.1bn (USD 1,000m) in cash and SEK 4.5bn (USD 500m) equivalent in newly issued Sobi
This is an important step towards reducing the treatment burden of people with HT-1 and it follows Sobi
's introduction of Orfadin oral suspension and 20 mg capsules, said Bob McLay, Vice President and General Manager of Sobi
In addition, building on the companies' long and successful relationship Sobi
has decided to move production of Kineret drug substance to Pfizer's manufacturing site in Strangnas, Sweden.
In early 2013, Sobi
announced that the US Food and Drug Administration (FDA) had approved Kineret for the treatment of children and adults with neonatal-onset multisystem inflammatory disease (NOMID), the most severe form of Cryopyrin-Associated Periodic Syndromes (CAPS).
18 June 2012 - Nordea and Skandinaviska Enskilda Banken AB (SEB) have handled the SEK600m (USD86m/EUR68m) bond issue of Swedish Orphan Biovitrum AB (STO:BVT), or Sobi
, the pharmaceutical company said on Monday.
's bicycles are engineered with an on-board computer, mobile communications and an integrated GPS-enabled lock and "this disruptive product and the supporting mobile and web applications will create a flexible, scalable, and affordable bike sharing system," say the SoBi
developers.The smart bike sharing system likely be available by end of the summer.
expects the acquisition to be earnings neutral in 2019.
"The HT-1 patient journey - from early screening and diagnosis, to improved medical care associated with continuous higher survival rates - has driven Sobi
's commitment to develop new strengths and formulations for Orfadin to continually meet the medical needs of HT-1 patients", says Michael Yeh, Vice President Medical Affairs.
"I am delighted that we have expanded our successful partnership with PharmaSwiss and provide patients and physicians with additional treatment options that address unmet medical needs in each specific therapeutic category", said Alan Raffensperger, senior vice president and Chief Operating Officer at Sobi
Biopharmaceutical company Swedish Orphan Biovitrum AB (Sobi
) (STO:SOBI) reported on Wednesday profit of SEK499m, or EPS of SEK1.70, for the second quarter of 2019.